Psilocybin Personality Changes and Why Researchers Are Interested
Psilocybin, the active compound found in certain psychedelic mushrooms, has gained attention for its potential mental health benefits. Beyond reducing symptoms of depression or anxiety, researchers are now asking a deeper question: can psilocybin lead to lasting changes in personality or personal values? Understanding this could help explain why some people report meaningful life shifts after psychedelic-assisted therapy.
Personality traits and values are typically considered stable in adulthood. Traditional psychiatric treatments rarely alter how people see themselves or what they prioritize in life. Psilocybin challenges this assumption by suggesting that certain experiences may temporarily loosen rigid mental patterns and create space for psychological change.
What This New Study Looked At
A recent placebo-controlled trial examined how psilocybin affects personality, psychiatric symptoms, and personal values in healthy volunteers. Participants received either a single dose of psilocybin or a placebo under carefully controlled conditions. Researchers followed them for several months to determine whether any changes extended beyond the acute psychedelic experience.
The study measured personality traits using established tools such as the Big Five model, assessed psychiatric symptoms including anxiety and mood changes, and evaluated shifts in personal values using a structured questionnaire. Importantly, the researchers also analyzed whether specific features of the psychedelic experience helped explain any observed changes.
Key Findings on Personality and Mental Health
Psilocybin did not produce significant differences in personality traits or psychiatric symptoms compared to placebo. Measures of openness, neuroticism, and overall psychological distress remained largely unchanged. Cognitive flexibility, another area of interest, also showed no clear advantage for psilocybin in this healthy population.
These findings are important because they suggest that a single dose of psilocybin does not dramatically reshape core personality traits in individuals without psychiatric conditions. This adds nuance to popular narratives that psychedelics universally change who people are at a fundamental level.
Psilocybin Personality Changes and Shifts in Values
Where psilocybin did stand out was in changes to personal values. Participants who received psilocybin reported greater shifts in life priorities and overall outlook compared to those who received placebo. These changes were observed one week after dosing and remained evident nearly three months later.
Researchers found that specific elements of the acute psychedelic experience played a key role. A phenomenon known as oceanic boundlessness, often described as a sense of unity, emotional openness, or deep connection, partially explained why participants reported lasting value changes. In some cases, sensory alterations such as changes in sound perception also contributed.
These results suggest that it is not simply the pharmacological effect of psilocybin, but the quality of the subjective experience, that may drive longer-term psychological outcomes.
Why These Findings Matter for Psychedelic Therapy
For clinicians and researchers working in psychedelic-assisted therapy, these findings help clarify what psilocybin may and may not influence. While the substance does not appear to directly alter stable personality traits in healthy individuals, it may shape how people reflect on meaning, purpose, and personal values.
This distinction has important implications for treatment design. Preparation and integration sessions may be especially critical, helping individuals process experiences that influence values without assuming automatic personality transformation. The findings also reinforce why context, guidance, and therapeutic framing are central to responsible psychedelic care.
What Comes Next for Research
The authors emphasize that these results are preliminary and based on a relatively small sample size. Larger studies are needed, particularly in clinical populations such as individuals with depression or anxiety disorders. Future research will also explore whether repeated dosing, different therapeutic models, or longer follow-up periods lead to broader or more durable changes.
As psychedelic-assisted therapy continues to evolve, understanding how subjective experiences translate into real-world psychological change will be essential for safe and effective clinical application.
Citations
Kerr-Gaffney J, Myrtle S, Askari F, et al. Effects of psilocybin on personality, psychiatric symptoms, and values. Journal of Psychopharmacology. 2025.
https://journals.sagepub.com/doi/10.1177/02698811251408769
Carhart-Harris RL, Goodwin GM. The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology. 2017.
https://pubmed.ncbi.nlm.nih.gov/28443617/